Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-α antibodies and tyrphostin

1997 ◽  
Vol 4 (8) ◽  
pp. 670-684 ◽  
Author(s):  
Carmen C. Solorzano ◽  
Shawn C. Jones ◽  
Mark Pettitjean ◽  
Thomas G. O'Daniel ◽  
Troy Auffenberg ◽  
...  
1992 ◽  
Vol 12 (4) ◽  
pp. 293-302 ◽  
Author(s):  
A. L. Thornley ◽  
G. J. Jones

Transforming growth factor alpha (TGF-α) is a single chain polypeptide which exists in a variety of forms differing in molecular weight. These forms are variously present in normal and neoplastic cells. Of particular interest are TGF-α's well-known mitogenic properties. The transition from a normal to a neoplastic cellular state results from signalling defects that may depend upon, iter alia, abonormal levels of expression and secretion of TGF-α. It is known that the secretion of TGF-α may be enhanced appreciably by agents such as phorbol 12-myristate 13-acetate (PMA), serum factors and epidermal growth factor (EGF). Here, we compare the efficacy of these three agents in the elevation of TGF-α secretion in the well studied A431 cell line with their previously undocumented efficacy in certain interesting, but little known, human oesophageal squamous cell carcinoma (SCC) lines.


Cancer ◽  
2003 ◽  
Vol 97 (7) ◽  
pp. 1701-1710 ◽  
Author(s):  
Patricia J. McLaughlin ◽  
Brendan C. Stack ◽  
Roger J. Levin ◽  
Fred Fedok ◽  
Ian S. Zagon

Sign in / Sign up

Export Citation Format

Share Document